サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1758172

デジタル・ワクチンの世界市場

Digital Vaccines

出版日
ページ情報
英文 274 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
デジタル・ワクチンの世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 274 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デジタル・ワクチンの世界市場は2030年までに31億米ドルに達する

2024年に18億米ドルと推定されるデジタル・ワクチンの世界市場は、2024年から2030年にかけてCAGR 9.2%で成長し、2030年には31億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるスマートフォン・デバイスは、CAGR 9.8%を記録し、分析期間終了時には20億米ドルに達すると予測されます。タブレット端末セグメントの成長率は、分析期間中CAGR 7.6%と推定されます。

米国市場は4億9,650万米ドルと推定、中国はCAGR12.7%で成長予測

米国のデジタル・ワクチン市場は、2024年に4億9,650万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを12.7%として、2030年までに6億2,780万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.5%と8.1%と予測されています。欧州では、ドイツがCAGR約7.2%で成長すると予測されています。

世界のデジタル・ワクチン市場- 主要動向と促進要因まとめ

デジタル・ワクチンとは何か、なぜ予防ヘルスケアを再定義するのか？

デジタル・ワクチンは、予防医療における新しいパラダイムを象徴しています。デジタルプラットフォームと神経認知トレーニングを活用することで、生物学的薬剤ではなく、行動条件付けと神経調節を介して、行動に影響を与え、回復力を高め、病気に対する免疫力を強化します。デジタル・ワクチンは、スマートフォンやタブレット、バーチャルリアリティシステムを通じて提供されるソフトウェアベースの介入策で、行動を変化させ、精神的・生理的反応パターンを改善することによって、ストレス、不安、中毒、あるいは感染症などの症状を予防するように設計された構造化されたエクササイズにユーザーを参加させます。

抗原を通して免疫反応を刺激する従来のワクチンとは異なり、デジタル・ワクチンは脳回路を活性化することで神経系を訓練し、行動免疫力を高める。このような解決策は、メンタルヘルス障害、行動依存症、生活習慣病への取り組みに特に関連しています。例えば子供の場合、デジタル・ワクチンは社会性と情動の学習と認知スキルを促進し、不安や仲間からのプレッシャーによる行動への影響を軽減するために開発されています。大人では、ストレス反応を調整し、喫煙や飲酒の習慣を減らし、認知的レジリエンスを促進することを目的としたツールが開発されています。

デジタル・ワクチン・プラットフォームの登場を後押しするテクノロジーとは？

デジタル・ワクチンは、人工知能、ゲーミフィケーション、神経行動学的アルゴリズム、適応学習モデルなど、さまざまな認知コンピューティング技術に依存しています。モバイルアプリケーションは主要な配信インターフェースとして機能し、AIはユーザーの行動データやパフォーマンスパターンに基づいて認知タスクをカスタマイズするために使用されます。ニューロフィードバック、アイトラッキング、バイオメトリック・モニタリングも、エンゲージメントを測定し、介入を動的に調整するために組み込まれています。

機械学習モデルがリアルタイムのデータを分析し、介入の強度、期間、複雑さを最適化することで、利用者が適切な「量」のデジタル療法を受けられるようにします。拡張現実（AR）や仮想現実（VR）のインターフェイスは、特に不安の軽減や恐怖症の脱感作のために、没入感と有効性を高めるために使用されています。一部のプラットフォームは、心拍変動やガルバニック皮膚反応のようなストレスマーカーをモニターするためにウェアラブルと統合されており、デジタルワクチンセッションの認知負荷や反応プロファイルの調整に役立っています。

デジタルワクチン技術の採用を促進しているエンドユースセグメントは？

教育分野、特にK-12や幼児教育プログラムは、デジタル・ワクチンを最も積極的に採用している企業の1つであり、子供たちの情緒的知性、自己調整能力、社会的適応力を高めるために利用しています。これらのツールは、学習カリキュラムに組み込まれたり、スタンドアローンのアプリケーションとして展開されたりして、特に傷つきやすい人々やトラウマの影響を受けた人々の心理的な準備態勢を向上させています。小児医療のプロバイダーは、ADHD、行動療法、自閉症スペクトラムへの介入の補助としてデジタル・ワクチンを検討しています。

企業のウェルネスやメンタルヘルスプログラムにおいて、デジタル・ワクチンは従業員の燃え尽き症候群を緩和し、認知機能を改善し、感情的な回復力を訓練するために人気を集めています。ヘルスケアシステムや保険会社は、特にハイリスク集団において、非臨床予防ケアとしてこれらのツールを評価し始めています。デジタル・セラピューティクス企業や神経科学の新興企業も、薬物乱用、うつ病、慢性ストレスなどの問題に対する病態特異的ワクチンを発売しており、行動医学におけるデジタルヘルスの役割を拡大しています。

デジタル・ワクチン市場の成長を促進する要因とは？

デジタル・ワクチン市場の成長は、スケーラブルなメンタルヘルス介入に対するニーズの高まり、非医薬品的予防医療の受け入れ拡大、認知健康プラットフォームへの投資増加など、いくつかの要因によって牽引されています。精神障害、ライフスタイルに起因する健康問題、あらゆる年齢層における行動リスク要因の増加により、政府や雇用主は利用しやすく費用対効果の高いソリューションを求めています。

モバイルヘルスアプリの普及、ウェルネスプログラムにおける行動AIの導入の増加、デジタル治療薬の臨床ケアへの統合、教育現場における感情学習の重視の拡大などのエンドユースの動向が、採用に拍車をかけています。さらに、神経科学、行動科学、デジタル技術の融合により、デジタルワクチンの有効性を継続的に改善することが可能になっています。ヘルスケアがパーソナライズされたプロアクティブなケアモデルへとシフトする中、デジタル・ワクチンは、認知科学とデジタルアクセシビリティを融合させ、精神的・行動的な幸福を守る世界ヘルス予防ツールキットの重要なレイヤーとして浮上しています。

セグメント

デバイス（スマートフォンデバイス、タブレットデバイス、その他デバイス）;アプリケーション（糖尿病アプリケーション、感染症アプリケーション、心血管疾患アプリケーション、その他アプリケーション）

調査対象企業の例（全34件）

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech International
  • BioNTech SE
  • CanSino Biologics Inc.
  • CureVac N.V.
  • Dynavax Technologies Corp.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc（GSK）
  • Inovio Pharmaceuticals Inc.
  • Johnson & Johnson Services
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India
  • Sinovac Biotech Ltd.
  • Stablepharma Ltd
  • Vaxart, Inc.

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36721

Global Digital Vaccines Market to Reach US$3.1 Billion by 2030

The global market for Digital Vaccines estimated at US$1.8 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Smartphones Device, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Tablets Device segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$496.5 Million While China is Forecast to Grow at 12.7% CAGR

The Digital Vaccines market in the U.S. is estimated at US$496.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$627.8 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Global Digital Vaccines Market - Key Trends & Drivers Summarized

What Are Digital Vaccines and Why Are They Redefining Preventive Healthcare?

Digital vaccines represent a new paradigm in preventive health, utilizing digital platforms and neurocognitive training to influence behavior, boost resilience, and strengthen immunity against disease-not through biological agents, but via behavioral conditioning and neural modulation. Delivered via smartphones, tablets, or virtual reality systems, digital vaccines are software-based interventions that engage users in structured exercises designed to prevent conditions such as stress, anxiety, addiction, or even infectious diseases by altering behavior and improving mental and physiological response patterns.

Unlike conventional vaccines that stimulate an immune response through antigens, digital vaccines operate by activating brain circuits to train the nervous system and enhance behavioral immunity. These solutions are especially relevant in tackling mental health disorders, behavioral dependencies, and lifestyle diseases. In children, for example, digital vaccines are being developed to promote social-emotional learning and cognitive skills to reduce susceptibility to anxiety or peer pressure-induced behaviors. In adults, these tools aim to condition stress responses, reduce smoking or drinking habits, and promote cognitive resilience.

Which Technologies Are Powering the Emergence of Digital Vaccine Platforms?

Digital vaccines rely on an array of cognitive computing technologies, including artificial intelligence, gamification, neurobehavioral algorithms, and adaptive learning models. Mobile applications serve as the primary delivery interface, while AI is used to customize cognitive tasks based on the user’s behavioral data and performance patterns. Neurofeedback, eye tracking, and biometric monitoring are also being incorporated to measure engagement and tailor interventions dynamically.

Machine learning models analyze real-time data to optimize intervention intensity, duration, and complexity, ensuring that users receive the right “dose” of digital therapy. Augmented reality (AR) and virtual reality (VR) interfaces are being used to enhance immersion and efficacy, particularly for anxiety reduction or phobia desensitization. Some platforms integrate with wearables to monitor stress markers like heart rate variability or galvanic skin response, which helps in calibrating the cognitive load and response profile of the digital vaccine session.

Which End-Use Segments Are Driving Adoption of Digital Vaccine Technologies?

The education sector, especially K-12 and early childhood programs, is one of the most active adopters of digital vaccines, using them to build emotional intelligence, self-regulation, and social adaptability among children. These tools are embedded into learning curriculums or deployed as standalone applications to improve psychological readiness, particularly in vulnerable or trauma-affected populations. Pediatric healthcare providers are exploring digital vaccines as adjuncts to ADHD, behavioral therapy, and autism spectrum interventions.

In corporate wellness and mental health programs, digital vaccines are gaining popularity to mitigate burnout, improve cognitive function, and train emotional resilience among employees. Healthcare systems and insurers are beginning to evaluate these tools for non-clinical preventive care, particularly in high-risk populations. Digital therapeutics firms and neuroscience startups are also launching condition-specific vaccines for issues like substance abuse, depression, and chronic stress, expanding the role of digital health in behavioral medicine.

What Factors Are Driving the Growth of the Digital Vaccines Market?

The growth in the digital vaccines market is driven by several factors, including the increasing need for scalable mental health interventions, growing acceptance of non-pharmaceutical preventive care, and rising investment in cognitive health platforms. The rising burden of mental disorders, lifestyle-induced health problems, and behavioral risk factors across all age groups is pushing governments and employers to seek accessible and cost-effective solutions-something digital vaccines are well-positioned to offer.

End-use trends such as the proliferation of mobile health apps, the rising deployment of behavioral AI in wellness programs, integration of digital therapeutics into clinical care, and expanding emphasis on emotional learning in educational settings are fueling adoption. Moreover, the convergence of neuroscience, behavioral science, and digital technology is enabling continuous refinement of digital vaccine efficacy. As healthcare shifts toward personalized and proactive care models, digital vaccines are emerging as a vital layer in the global health prevention toolkit-blending cognitive science with digital accessibility to protect mental and behavioral well-being.

SCOPE OF STUDY:

The report analyzes the Digital Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Smartphones Device, Tablets Device, Other Devices); Application (Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech International
  • BioNTech SE
  • CanSino Biologics Inc.
  • CureVac N.V.
  • Dynavax Technologies Corp.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc (GSK)
  • Inovio Pharmaceuticals Inc.
  • Johnson & Johnson Services
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India
  • Sinovac Biotech Ltd.
  • Stablepharma Ltd
  • Vaxart, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Digital Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Focus on Neurological and Behavioral Health Drives Interest in Cognitive-Based Digital Vaccines
    • OEM Development of Game-Like Therapeutic Platforms Throws Spotlight on Software-Based Immunomodulation
    • Clinical Validation of Neuromodulatory Mechanisms Strengthens Evidence Base for Digital Vaccine Efficacy
    • Rising Burden of ADHD, PTSD, and Anxiety Fuels Demand for Non-Invasive Behavioral Interventions
    • Integration of AI-Driven Personalization Enhances Cognitive Engagement in Digital Vaccine Delivery
    • Expansion of Prescription Digital Therapeutics (PDT) Framework Supports Regulatory Approvals
    • Digital Vaccine Development Benefits From Neuroplasticity Research and Stimulus Design Advancements
    • Use of Smartphones and Tablets as Delivery Platforms Increases Accessibility in Pediatric Populations
    • FDA and EMA Recognition of Software as a Medical Device (SaMD) Framework Accelerates Market Entry
    • Increased Use in Cognitive Training and Prevention of Neurodegenerative Disorders Broadens Applications
    • Rising Healthcare Cost Pressures Drive Interest in Scalable, Low-Cost Software-Based Interventions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Vaccines Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Digital Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Smartphones Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Smartphones Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Smartphones Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Tablets Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Tablets Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Tablets Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Diabetes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Digital Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Digital Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Digital Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Digital Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Digital Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Digital Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Digital Vaccines by Device - Smartphones Device, Tablets Device and Other Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Digital Vaccines by Device - Percentage Breakdown of Value Sales for Smartphones Device, Tablets Device and Other Devices for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Digital Vaccines by Application - Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Digital Vaccines by Application - Percentage Breakdown of Value Sales for Diabetes Application, Infectious Diseases Application, Cardiovascular Diseases Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION